Patents Assigned to ForwardVue Pharma, Inc.
  • CAI nanoemulsions
    Patent number: 12594262
    Abstract: The present disclosure relates to nanoemulsions of 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide (carboxy-amido-triazole or CAI), methods of preparing thereof, and their use in the treatment of inflammatory optic neuropathies.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: April 7, 2026
    Assignee: ForwardVue Pharma, Inc.
    Inventors: Alan J. Franklin, Laurent Balenci, Srikanth Kakamanu, Robert Dempsey